Exagen Inc. XGN EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Exagen Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s EBIT?
- Exagen Inc. (XGN) reported EBIT of -$3.41M in Q1 2026.
- How has Exagen Inc.'s EBIT changed year-over-year?
- Exagen Inc.'s EBIT decreased by 1.5% year-over-year, from -$3.37M to -$3.41M.
- What is the long-term trend for Exagen Inc.'s EBIT?
- Over 4 years (2021 to 2025), Exagen Inc.'s EBIT has grown at a -12.6% compound annual growth rate (CAGR), from -$24.07M to -$14.07M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.